Related Experiment Videos
Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease
J C Burns1, C Shimizu, H Shike
1Department of Pediatrics-0830, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA. jcburns@ucsd.edu
Genes and Immunity
|May 13, 2005
Summary
Genetic variations in the interleukin-4 (IL-4) gene are linked to Kawasaki disease (KD) susceptibility. This study found asymmetric transmission of IL-4 alleles in KD patients, suggesting its role in disease development.
Area of Science:
- Genetics
- Immunology
- Pediatric Cardiology
Background:
- Kawasaki disease (KD) is an acute childhood vasculitis leading to coronary artery aneurysms.
- Genetic factors are suspected to influence KD susceptibility.
- Previous studies indicated potential links between KD and immune system genes.
Purpose of the Study:
- To investigate the association between genetic variations in cardiovascular and inflammation-related genes and KD susceptibility.
- To identify specific genes or genetic regions contributing to KD pathogenesis.
Main Methods:
- A family-based genotyping study was conducted using the transmission disequilibrium test (TDT).
- Analysis included 209 KD trios in the primary cohort and 60 trios in a replication cohort.
- 58 candidate genes involved in cardiovascular disease and inflammation were genotyped.
Main Results:
- Asymmetric transmission of five alleles was observed, notably the interleukin-4 (IL-4) C(-589)T allele (P=0.03), replicated in an independent cohort (combined P=0.002).
- Asymmetric transmission was also found for haplotypes within the IL-4 gene cluster on chromosome 5q31, including CSF2, IL-13, and TCF7.
- These findings suggest a significant genetic link between the IL-4 gene region and KD susceptibility.
Conclusions:
- Genetic variation in the IL-4 gene, or linked regions, plays a significant role in Kawasaki disease pathogenesis.
- The study provides strong evidence supporting the involvement of IL-4 in KD susceptibility.
- Further research into the IL-4 pathway could offer insights into KD prevention and treatment.